DK445585D0 - Stof-konjugeret komplementkomponent clq - Google Patents

Stof-konjugeret komplementkomponent clq

Info

Publication number
DK445585D0
DK445585D0 DK445585A DK445585A DK445585D0 DK 445585 D0 DK445585 D0 DK 445585D0 DK 445585 A DK445585 A DK 445585A DK 445585 A DK445585 A DK 445585A DK 445585 D0 DK445585 D0 DK 445585D0
Authority
DK
Denmark
Prior art keywords
conjuged
complement component
component clq
clq
complement
Prior art date
Application number
DK445585A
Other languages
English (en)
Other versions
DK445585A (da
Inventor
Fumiaki Taguchi
Isamu Mitsui
Kinichi Hara
Masaro Hayashi
Kunio Ezawa
Kenichi Fukunaga
Jun Kuranari
Original Assignee
Calpis Food Ind Co Ltd
Fumiaki Taguchi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59205686A external-priority patent/JPS6184560A/ja
Priority claimed from JP59223049A external-priority patent/JPS61102558A/ja
Priority claimed from JP10389885A external-priority patent/JPS61263928A/ja
Priority claimed from JP60162012A external-priority patent/JPS6224148A/ja
Priority claimed from JP60166004A external-priority patent/JPS6227663A/ja
Application filed by Calpis Food Ind Co Ltd, Fumiaki Taguchi filed Critical Calpis Food Ind Co Ltd
Publication of DK445585D0 publication Critical patent/DK445585D0/da
Publication of DK445585A publication Critical patent/DK445585A/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/003Thiazine dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043Fluorescein, used in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056Peptides, proteins, polyamino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK445585A 1984-10-02 1985-10-01 Stof-konjugeret komplementkomponent clq DK445585A (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP59205686A JPS6184560A (ja) 1984-10-02 1984-10-02 補体結合性抗体の測定法
JP59223049A JPS61102558A (ja) 1984-10-25 1984-10-25 抗原の測定法
JP10389885A JPS61263928A (ja) 1985-05-17 1985-05-17 補体成分と物質の結合物及びその製造法
JP60162012A JPS6224148A (ja) 1985-07-24 1985-07-24 中和抗体の迅速測定法
JP60166004A JPS6227663A (ja) 1985-07-29 1985-07-29 細胞内の物質、微細生物の測定法

Publications (2)

Publication Number Publication Date
DK445585D0 true DK445585D0 (da) 1985-10-01
DK445585A DK445585A (da) 1986-04-03

Family

ID=27526144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK445585A DK445585A (da) 1984-10-02 1985-10-01 Stof-konjugeret komplementkomponent clq

Country Status (3)

Country Link
EP (1) EP0177023A3 (da)
KR (1) KR890001538B1 (da)
DK (1) DK445585A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0420913B1 (en) * 1988-06-14 1995-11-15 Cell Med, Inc. Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
FR2687680A1 (fr) * 1992-02-20 1993-08-27 Centre Nat Rech Scient Procede de marquage de proteines et de peptides par acylation de leur fonction alpha aminee par un reactif comportant une fonction carboxylique activee.
AT409801B (de) * 2000-05-31 2002-11-25 Cistem Biotechnologies Gmbh Verfahren zum screenen und isolieren von mikroorganismen, insbesondere prokaryontischer und eukaryontischer zellen, die ein antigen präsentieren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
SE404553B (sv) * 1977-03-04 1978-10-09 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner

Also Published As

Publication number Publication date
DK445585A (da) 1986-04-03
EP0177023A2 (en) 1986-04-09
KR890001538B1 (ko) 1989-05-06
KR860003023A (ko) 1986-05-19
EP0177023A3 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
AT380762B (de) Hoergeraet
ATA40585A (de) Aeusserlich einsetzbarer minifixator
AT379929B (de) Hoergeraet
DE3561395D1 (de) Phenylisothiocyanates
DK1585A (da) Cephalosporinantibiotica
ATA98284A (de) Schalplatte
DK346285D0 (da) Toermursystem
DK117985D0 (da) Glyceroletherphosphatider
ATA135485A (de) Maishaecksler
FR2561239B1 (fr) Arylthio-pyridinyl-alcanols
DK80885D0 (da) Dentalsut
AT386724B (de) Haecksler
DK405885A (da) Etherherbicider
DK606385D0 (da) Acylaminoergoliner
DK445585A (da) Stof-konjugeret komplementkomponent clq
BR8407371A (pt) Microinterruptor
PT79789A (de) Winkelschraubvorrichtung
DK161783C (da) Roerformet lyddaemper
AT389296B (de) Elektrokoagulator
DK195885D0 (da) Helkappecentrifuge
BR8402733A (pt) Divisoria
FI840140A0 (fi) Torkanordning foer fast braensle
DK33086D0 (da) Specialpotte
AR231237A1 (es) Calzado-patin
ES280288Y (es) Manta-edredon

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment